Sign in

CIK 0001088856

  • Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770487658
Phone
+1 650-688-8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
  1. 5 Insider Annual Insider Trading Report
  2. 5 Insider Annual Insider Trading Report
  3. 4 Open-market sale See Remarks sold 625 shares at $25.28 ($15,800)
  4. 4 Open-market sale Chief Business Officer sold 5,000 shares at $26.03 ($130,150)
  5. 4 Open-market sale Chief Business Officer sold 23,401 shares at an average $26.27 ($614,788)
  6. 4 Open-market sale See Remarks sold 25,000 shares at $25.57 ($639,250)
  7. 4 Open-market sale See Remarks sold 25,000 shares at $25.64 ($641,000)
  8. 4 Shares withheld for taxes Chief Scientific Officer gave up 29,997 shares (to pay taxes)
  9. 4 Open-market sale Chief Business Officer sold 50,000 shares at $26.06 ($1,303,000)
  10. 4 Grant or award Chief Business Officer acquired 2,020 shares (grant or award)
  11. 4 Open-market sale See Remarks sold 25,000 shares at $25.84 ($646,000)
  12. 4 Grant or award Chief Financial Officer acquired 1,586 shares (grant or award)
  13. 4 Grant or award Chief Development Officer acquired 1,844 shares (grant or award)
  14. 4 Shares withheld for taxes Chief Business Officer gave up 93,922 shares (to pay taxes)
  15. 4 Option exercise See Remarks acquired 15,000 shares (option exercise)
  16. 4 Option exercise See Remarks acquired 24,800 shares (option exercise)
  17. 4 Open-market sale See Remarks sold 200 shares at $28.70 ($5,740)
  18. 4 Open-market sale Director sold 15,385 shares at $28.32 ($435,703)
  19. 4 Open-market sale See Remarks sold 25,000 shares at $27.37 ($684,250)
  20. 4 Open-market sale Chief Executive Officer sold 335,019 shares at an average $26.26 ($8,798,952)

Page 18 of 60 · 1,197 filings